Pharmacokinetics of Coadministered Viloxazine Extended-Release (SPN-812) and Lisdexamfetamine in Healthy Adults

BACKGROUND: Viloxazine extended-release is a novel nonstimulant under investigation as a potential treatment for attention-deficit/hyperactivity disorder (ADHD). Given the potential for viloxazine extended-release to be co-administered with stimulant ADHD pharmacotherapies, this trial investigated t...

Descripción completa

Detalles Bibliográficos
Autores principales: Faison, Shamia L., Fry, Nicholas, Adewole, Toyin, Odebo, Oyinkansola, Wang, Zhao, Maletic, Vladimir, Nasser, Azmi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919699/
https://www.ncbi.nlm.nih.gov/pubmed/33587403
http://dx.doi.org/10.1097/JCP.0000000000001361

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7919699/
https://www.ncbi.nlm.nih.gov/pubmed/33587403
http://dx.doi.org/10.1097/JCP.0000000000001361

Ejemplares similares